Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Neoplasms 7Breast Neoplasms 6Colorectal Neoplasms 5Prostatic Neoplasms 4Head and Neck Neoplasms 4Lung Neoplasms 3Glioblastoma 3Stomach Neoplasms 2Pancreatic Neoplasms 2Motor Activity 2Malnutrition 2Liver Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Upper Excretory Tract Tumors 1Ulcer 1Thrombosis 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sleep Disorders, Circadian Rhythm 1Sezary Syndrome 1Seizures 1Rectal Neoplasms 1Radiodermatitis 1Radiation Induced Oral Mucositis 1Pulmonary Disease, Chronic Obstructive 1Pulmonary Atelectasis 1

Interventions

vilanterol 1Tiotropium Bromide 1Therapeutics 1Standard of Care 1Salmeterol Xinafoate 1Fluticasone-Salmeterol Drug Combination 1Fluticasone 1Budesonide 1Albuterol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pulmonary Disease, Chronic Obstructive × Standard of Care × Clear all
NCT00678405 2010-06-25

Trial of a Breathlessness Intervention Service for Intractable Breathlessness

Cambridge University Hospitals NHS Foundation Trust

Phase 3 Unknown
120 enrolled
OtherThoracic

Dyspnea, Heart Failure, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡